Lenacapavir, an antiretroviral drug typically used to treat HIV infections, can also effectively prevent them, a phase 3 ...

Approved by the FDA 12 years ago, pre-exposure prophylaxis (PrEP) has significantly reduced the risk of HIV transmission and ...

A recent phase 3 trial found that twice-yearly injections of Lenacapavir reduce the risk of contracting HIV by 96%. | Drug ...

"PrEP reduces the risk of getting HIV from sex by about 99 percent when taken as prescribed. Although there is less ...

But Woodward said the increase could be slowed down if there was greater uptake in drugs that prevent HIV transmission, ...

With new CDC data expressing optimism about the epidemic of sexually transmitted infections (STIs), take a look at the ...

On Worlds AIDS Day, the benefits of PEPFAR, PrEP, and U=U are celebrated. But continuing stigma and decreasing political will ...

With Sunday marking the 37th annual World AIDS Day, the Michigan Department of Health and Human Services (DHHS) released its ...

Recent results from a recent clinical trial indicate that a twice-yearly injection of Lenacapavir offers an overall 96% reduced risk of acquiring HIV. This makes Lenacapavir significantly more ...

President Joe Biden on Sunday displayed the AIDS Memorial Quilt on the White House South Lawn to observe World AIDS Day ...

Yesterday, World AIDS Day, Bay Area church services acknowledged lives lost in the HIV/AIDS pandemic and elected officials ...